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Abstract
Background:  Calreticulin is a Ca2+ binding chaperone of the endoplasmic reticulum which
influences gene expression and cell adhesion. The levels of both vinculin and N-cadherin are
induced by calreticulin expression, which play important roles in cell adhesiveness. Cardiac
development is strictly dependent upon the ability of cells to adhere to their substratum and to
communicate with their neighbours.
Results: We show here that the levels of N-cadherin are downregulated in calreticulin-deficient
mouse embryonic hearts, which may lead to the disarray and wavy appearance of myofibrils in these
mice, which we detected at all investigated stages of cardiac development. Calreticulin wild type
mice exhibited straight, thick and abundant myofibrils, which were in stark contrast to the thin, less
numerous, disorganized myofibrils of the calreticulin-deficient hearts. Interestingly, these major
differences were only detected in the developing ventricles while the atria of both calreticulin
phenotypes were similar in appearance at all developmental stages. Glycogen also accumulated in
the ventricles of calreticulin-deficient mice, indicating an abnormality in cardiomyocyte metabolism.
Conclusion: Calreticulin is temporarily expressed during heart development where it is required
for proper myofibrillogenesis. We postulate that calreticulin be considered as a novel cardiac fetal
gene.
Background
Calreticulin is a ubiquitous calcium-binding protein with
wide tissue distribution found in all eukaryotic cells with
the exception of yeast [1], whose remarkable conservation
implies an important biological function. In the lumen of
the endoplasmic reticulum (ER), calreticulin functions as
a calcium buffer and a lectin-like molecular chaperone
[2], and it also modulates cell adhesiveness by regulating
the expression of several genes encoding adhesion pro-
teins, namely vinculin – a cytoskeletal protein and N-cad-
herin, a cell membrane protein [3-6]. Although
calreticulin was originally discovered in striated muscle
[7-9], its expression there is very low and no clear role has
been attributed to calreticulin in striated muscle thus far
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[10]. Interestingly, ablation of calreticulin by homolo-
gous recombination is embryonic lethal due to faulty car-
diac organogenesis [11]. Although viable calreticulin
knockout (KO) embryos were obtained as late as 18.5
days  post coitum (dpc), the majority of embryos died
between 12.5 and 14.5 dpc [11,12]. Light microscopical
analysis of KO embryos revealed a marked decrease in
ventricular wall thickness, deep intertrabecular recesses,
and increased fenestration in the ventricular walls. No sig-
nificant histological changes in the atrial wall were
observed at the light microscope level [11]. These findings
were unexpected as calreticulin abundance in adult car-
diac tissue is very low [9]. To determine the activation of
the calreticulin promoter, transgenic mice expressing a
Green Fluorescent Protein (GFP) reporter gene under con-
trol of the calreticulin promoter were previously generated
by us, and we have shown that the activation of the calre-
ticulin promoter occurred in a highly restricted spatiotem-
poral pattern during development [11]. The most intense
GFP fluorescence occurred in the cardiovascular system at
day 9.5 of embryonic development. The highest expres-
sion of calreticulin in embryonic hearts was observed at
13.5 dpc [11]. In older embryos, the high activity of the
calreticulin promoter was maintained in the heart and
arteries, but it decreased progressively by day 18.5 of
embryonic development. Finally, a negligible level of flu-
orescence was detected in the heart of three-week old
transgenic mice [11]. These findings showed that the
activity of the calreticulin promoter is down regulated at
late stages of development and after birth, which are in
agreement with earlier observations that mature hearts
express a relatively low level of calreticulin [13]. Collec-
tively, these observations suggest that calreticulin plays an
important, albeit unknown, role in cardiac development
and function. The present study was undertaken to
unravel the ultrastructural effects of the absence of calreti-
culin on cardiac tissue morphogenesis using Transmission
Electron Microscopy (TEM).
Results
The following convention has been assumed in this man-
uscript regarding the description of the stages of heart
development: early stage of embryonic heart development
refers to 12.5 to 13.5 dpc; mid-stage refers to 14.5 to 15.5
dpc; and late stage refers to 16.5 to 18.5 dpc.
Expression of cardiac calreticulin
Western blotting of wild type (WT) hearts reveals that cal-
reticulin expression is regulated during embryonic devel-
opment (Fig. 1). Calreticulin is fairly abundant in both
embryonic atria and ventricles at 15–16 dpc, however, it
becomes downregulated and barely detectable in postna-
tal (P) and adult hearts.
Gross anatomy of the developing calreticulin KO mouse 
heart
Although the mouse heart is well developed by 12.5 dpc,
under the light microscope the trabeculae carnae and pap-
illary muscles are difficult to recognize. It is not until 16.5
dpc that the developing heart achieves its full prenatal
configuration. While this applies to both calreticulin phe-
notypes, calreticulin KO embryonic hearts are smaller
than WT and their ventricular walls are noticeably thinner
(not shown). Furthermore, there is a discernible increase
in the degree of trabeculation in the WT by 16.5 dpc,
which is not observed in calreticulin KO hearts, and which
explains the deep intertrabecular recesses previously
found in KO mouse hearts [11]. Such gross anatomical
differences between calreticulin KO and WT were not
detected in atria at any stage of embryonic development
investigated.
Myocardial ultrastructure of the calreticulin KO mouse 
heart during development
Myofibrillar disarray
General features of ventricular myocytes in calreticulin
KO and WT at an early stage of development are shown in
Fig. 2. In the early stage of embryonic development, ven-
tricular and atrial myofibrils of both calreticulin pheno-
types are generally confined to the periphery of
cardiomyocytes (Figs. 2A,B; 3A,B; 4A,B). During develop-
ment, myofibrils increase in number and extend into the
cell interior (Figs. 3C–F; 4C–F). At 12.5 dpc, these contrac-
tile elements exhibit myofibrillar disarray – a random ori-
entation of the fibrils in the ventricles. This myofibrillar
disarray is considerably more pronounced in the calreticu-
lin KO than in the WT (Fig. 2A,B; 3A,B). In comparison,
atrial myocardium is relatively unaffected (Fig. 4A,B). As
development progresses, calreticulin KO and WT ventricu-
lar myofibrils become less disarrayed and begin to align
parallel to the cardiomyocyte's longitudinal axis (Figs.
3C–F; 4C–F). Such increasing order in myofibrillar
arrangement in WT ventricular myocardium is seen as
early as 13.5 dpc, but only after 14.5 dpc in calreticulin
KO (Fig. 3C,D). At 18.5 dpc, calreticulin KO ventricular
myofibrils attain organization approximating that of the
WT (Fig. 3E,F), although some myofibrillar disarray is still
evident. In contrast to the ventricle, no delay in the myofi-
brillar organization is detected in the atrial myocardium
(Fig. 4).
Early embryonic myocardium is characterized by the pres-
ence of large areas of electro-lucent cytosol (Figs. 2A,B;
3A,B; 4A,B). As maturation proceeds, this clear cytosolic
fraction becomes reduced as the sarcoplasm becomes
packed with intracellular organelles. During the period
investigated, the cytosol of the atrial cardiomyocytes of
both phenotypes comprises a larger portion of the sarco-
plasm than that of the ventricular cardiomyocytes. Conse-BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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quently, the myofibrillar arrangement of the atrial
myocardium is less compact compared to the correspond-
ing ventricular myocardial tissue (compare Figs. 3 and 4).
Wavy appearance of myofibrils
During the early stage of embryonic development, myofi-
brils are only a few sarcomeres in length and are straight
A medium power overview of myofibrillar ultrastructure in the ventricular myocardium of WT (A) and calreticulin KO (B)  phenotypes Figure 2
A medium power overview of myofibrillar ultrastructure in the ventricular myocardium of WT (A) and calreticulin KO (B) 
phenotypes. Magnification 5,000×.
Western blot analysis of calreticulin expression during development of the heart Figure 1
Western blot analysis of calreticulin expression during development of the heart. Calreticulin is abundant in both atria (A) and 
ventricles (V) during embryonic development days post coitus (dpc). Calreticulin protein levels becomes barely detectable 
postnatally (P) and even more so in the adult heart. GAPDH serves as a loading control.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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Myofibrillar ultrastructure in the developing ventricular myocardium of WT (A, C, E) and calreticulin KO hearts (B, D, F) Figure 3
Myofibrillar ultrastructure in the developing ventricular myocardium of WT (A, C, E) and calreticulin KO hearts (B, D, F). Mag-
nification 10,000×. At 12.5 dpc, the ventricular myofibrils of both phenotypes are only a few sarcomeres in length (A and B). 
These early myofibrils exhibit disarray, which is considerably more pronounced in the calreticulin KO (B) than in the WT (A) 
ventricular myocardium. At 14.5 dpc, ventricular myofibrils of WT (C) and to a much lesser extent the calreticulin KO (D) 
become less disarrayed, and start to align with the long axis of the cardiomyocyte. At 18.5 dpc, most of the ventricular myofi-
brils of WT phenotype (E) run in straight courses aligned parallel to each other with their Z-lines in register, thus showing little 
if any myofibrillar disarray. Even thought calreticulin KO myofibrils become less disarrayed with embryonic development (F), 
their Z-lines are frequently not aligned (F). Calreticulin KO ventricular myofibrils, already wavier in their appearance than the 
corresponding WT ventricular myofibrils by 13.5 dpc, do not straighten with further embryonic development as their counter-
parts but become visibly wavier (C vs D). This difference in the degree of waviness is most noticeable at the latest stage of 
embryonic development investigated, 18.5 dpc (E vs F).BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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Myofibrillar ultrastructure in the developing atrial myocardium of WT (A, C, E) and calreticulin KO hearts (B, D, F) Figure 4
Myofibrillar ultrastructure in the developing atrial myocardium of WT (A, C, E) and calreticulin KO hearts (B, D, F). Magnifica-
tion 10,000×. In atrial myocardium, there was no difference between the degree of organization following myofibrillar disarray 
between the calreticulin phenotypes. Atrial myocardium of both phenotypes contains large amounts of cytosol. Consequently, 
the myofibrillar arrangement of the atrial myocardium is less compact compared to the corresponding ventricular myocardial 
tissue (A, B, C, D, E, and F). By 18.5 dpc, most of the WT and KO myofibrils of atrial myocardium run in straight courses 
aligned parallel to each other with their Z-lines in register (E and F).BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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in appearance (Figs. 2A,B; 3A,B; 4A,B). By 13.5–14.5 dpc,
when the number of sarcomeres per myofibril increases,
ventricular myofibrils acquire a wavy appearance (Fig.
3C,D; Fig. 4C,D). This waviness eventually disappears in
the WT: by 18.5 dpc, the WT ventricular myofibrils run in
straight courses aligned parallel to each other and with
their Z-lines in register (Fig. 3E). Calreticulin KO ventricu-
lar myofibrils are much wavier at 14.5 dpc than the corre-
sponding WT ventricular myofibrils (Fig. 3D).
Furthermore, calreticulin KO ventricular myofibrils do
not straighten with further embryonic development but
instead become visibly wavier (Fig. 3F).
To quantify the myofibrillar waviness, an angle a sarcom-
ere makes with a trajectory between the initial and the
final Z-line of the myofibril referred to as a sarcomeric
angle (Fig. 5), has been adopted as a measure. Fig. 6 shows
average sarcomeric angles for each calreticulin phenotype
at 14.5 and 18.5 dpc. Calreticulin KO myofibrils are sig-
nificantly wavier than the corresponding WT myofibrils
(Wilcoxon rank sum test, P << 0.001). Percent differences
in average sarcomeric angle between the WT and calreticu-
lin KO at 14.5 and 18.5 dpc are 148% and 238%, respec-
tively. Additional statistical analysis shows that there is a
significant increase of 35% in sarcomeric angle of calreti-
culin KO myofibrils between 14.5 and 18.5 dpc (Wil-
coxon rank sum test, P << 0.001). The myofibrillar
waviness seen in calreticulin KO ventricular myocardium
is not as pronounced in atrial myocardial tissue (Fig. 4C–
F).
Myofibrillar width
Statistical analysis of the median ventricular sarcomeric
width shows that calreticulin KO ventricular myofibrils
are significantly thinner than those of the WT at all devel-
opmental ages investigated (Wilcoxon rank sum test, P <
0.05). Fig. 7A shows a histogram of average sarcomeric
width of the ventricular myofibrils for each calreticulin
phenotype. The calreticulin KO ventricular myofibrils are
approximately 32% thinner than their WT counterparts.
Figure 8 shows stark differences in ventricular myofibril
width between the two phenotypes. In contrast, in the
early stages of atrial development, there is no significant
difference in the median sarcomeric width between the
two calreticulin phenotypes (Wilcoxon rank sum test, P >
0.05). However, thinning of atrial myofibrils in the calre-
ticulin KO heart becomes noticeable at the mid- and late
stages of embryonic development (Wilcoxon rank sum
test, P < 0.05) (Figs. 7B; 8).
Myofibrillar count
Calreticulin KO ventricular myocardium relative to WT is
characterized by a lower number of myofibrils at all stages
of embryonic development investigated (Fig. 9A). In con-
trast to the ventricle, there is no significant difference
between myofibrillar counts in the atria of calreticulin KO
and WT hearts early in development. However, the myofi-
brillar count becomes significantly lower in calreticulin
KO atria at mid- and late stages of development (t-test, P
< 0.05) (Fig. 9B).
Z-lines
Early in embryonic development, immature ventricular
and atrial Z-lines of both calreticulin phenotypes have an
irregular margin and variable width (Fig. 3A,B; Fig. 4A,B).
With maturation, these Z-lines narrow in width, lengthen,
and become more prominent (Figs. 3C–F; 4C–F). The Z-
lines of the WT ventricles and atria as well as the Z-lines of
the calreticulin KO atria are often in register by mid- to
late stages of embryonic development (Figs. 3C,E; 4C–F).
This is in contrast to the ventricular Z-lines of the calreti-
culin KO phenotype, which are not well aligned, even at
late stages of development (Fig. 3F).
Myocardial glycogen
Highly branched, large molecules of glycogen appear as
dark sarcoplasmic particles in electron micrographs. In
the developing WT ventricular and atrial cardiomyocytes,
glycogen is abundant, and its amount decreases with
embryonic maturation. By 18.5 dpc, glycogen occurs
mainly in large pools within the sarcoplasm, primarily
concentrated in spaces between the myofibrils, and
appears as large, light grey areas in electron micrographs
(Fig. 10). When these glycogen pools are found near the
contractile structures, they are usually located in apposi-
tion to I-bands. In contrast to WT, glycogen abundance
Measurement of the sarcomeric angle Figure 5
Measurement of the sarcomeric angle. An individual internal 
sarcomeric angle (α) was defined as an angle between a 
straight line connecting centres of adjacent Z-lines and a 
straight line connecting the centres of the initial and final Z-
line of a given myofibril. To obtain average sarcomeric angle, 
all individual sarcomeric angles of a myofibril were averaged.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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noticeably increases with development in calreticulin KO
ventricles (Fig. 10). At early stages of embryonic develop-
ment, there is just slightly more glycogen in calreticulin
KO ventricular sarcoplasm than in the corresponding WT
sarcoplasm (Fig 11). However, as development
progresses, there is a discernible and statistically signifi-
cant (t-test, P < 0.05) accumulation of glycogen in the sar-
coplasm of the calreticulin KO ventricular cardiomyocytes
(Fig. 11). No difference in glycogen deposition was
observed in the atrial myocardial tissue between the two
phenotypes (data not shown).
Intercalated discs
Early in embryonic development, immature ventricular
intercalated discs of the calreticulin KO and WT mice are
short, thin, and primarily oriented obliquely to the long
axis of the cardiomyocyte (Fig. 12A,B). However, as devel-
opment progresses, the intercalated discs become larger,
more complex, and predominantly oriented perpendicu-
larly to the cardiomyocyte axis (Fig. 12C,D). Additionally,
maturation of the ventricular intercalated discs of both
phenotypes is accompanied by increasing inter-digita-
tions as seen by late stages of embryonic development
(Fig. 12C,D). Quantitatively, statistical analysis reveals
that at 14.5 dpc, there is no significant difference in mean
ventricular number of intercalated discs between calreti-
culin KO and WT subject groups (Wilcoxon rank sum test:
P = 0.93). Intercalated discs of the WT ventricular myocar-
dium tend to cross cardiomyocytes in almost straight
lines, but occasionally they appear in a stepwise arrange-
ment. Interestingly, the intercalated discs of the calreticu-
lin KO ventricular myocardial tissue are more likely to run
in a stepwise fashion than the WT (not shown). No such
difference was noticed in the atrial myocardium.
Western blot analysis of N-cadherin and vinculin expression in 
embryonic heart
Western blotting of WT and KO embryonic hearts at 14
dpc reveals that N-cadherin is substantially downregu-
lated in calreticulin KO hearts when compared to the WT
tissue (Fig. 13). Vinculin abundance does not change with
ablation of calreticulin.
Discussion
Calreticulin-null embryos die during mid-gestation due to
defective heart development. Studies using mice contain-
ing GFP controlled by the calreticulin promoter showed
that indeed the calreticulin promoter is highly active at the
time of cardiac organogenesis but its activity decreases
and becomes undetectable postnatally [11]. In this work,
Western blotting revealed that the abundance of calreticu-
lin protein follows a similar time course to that of the pro-
moter. The novel finding presented here is that ablation of
calreticulin is paralleled by myofibrillar disarrangement
in the ventricular myocardium. No such changes are
observed in the atrial myocardium. In addition, the calre-
ticulin KO phenotype is characterized by a lower number
of myofibrils. The major signs of myofibrillar disarrange-
ment are random orientation, myofibrillar waviness and
thinning.
Early in embryonic development, myofibrils are confined
to the cardiomyocyte periphery. However, as the number
and size of these myofibrils increase during development,
they progressively extend into the cell interior. Myofibrils
early in development exhibit myofibrillar disarray, i.e.
myofibrils are randomly oriented in a section, and are not
aligned parallel to each other and the long-axis of the car-
diomyocyte. Such random orientation of the myofibrils is
a characteristic of immature myocardium under normal
conditions [17]. With the progression of embryonic devel-
opment, the WT myofibrils become more aligned with
one other and the long axis of the cardiomyocyte [18]. In
contrast, the developing ventricular myofibrils of the cal-
reticulin KO heart become aligned to one another and to
the long axis of the cardiomyocyte much later than the
ventricular myofibrils of the WT heart. This illustrates the
temporary nature of this myofibrillar disorganization.
The second feature of the ventricular KO myofibrils is
their wavy appearance. The waviness of WT myofibrils is
most pronounced at 13.5 dpc, after which the myofibrils
straighten out. Similar waviness has been described in
early rat myocardium [19]. In contrast, calreticulin KO
myofibrils become wavier in appearance with ongoing
development instead of straightening out. This difference
is most noticeable at 18.5 dpc. To verify if the myofibrillar
waviness was caused by a development delay, we com-
pared the morphology of calreticulin KO ventricular
myofibrils with WT myofibrils of earlier developmental
Histogram of average ventricular sarcomeric angle Figure 6
Histogram of average ventricular sarcomeric angle. Note the 
increase in sarcomeric angle of the KO ventricular sarcom-
eres compared to their WT counterparts, especially at 18.5 
dpc.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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Histogram of average sarcomeric width Figure 7
Histogram of average sarcomeric width. A: Note that the average sarcomeric width of the ventricular myofibrils is less than 
that of the WT myofibrils. B: Average sarcomeric width of atrial myofibrils. Commencement of thinning of the myofibrils in cal-
reticulin KO atria in comparison to WT (taken as 100%) is evident at 14.5 dpc.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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age. Such comparison revealed that the calreticulin KO
ventricular myofibrils of the late stage of embryonic devel-
opment do not resemble neither early nor mid-stage WT
ventricular myofibrils. Hence, the wavy characteristic of
the calreticulin KO ventricular myofibrils is not a result of
a developmental delay but is a result of a defect associated
with calreticulin deficiency.
What could be a mechanism by which calreticulin abla-
tion could affect myofibrillar organization? Calreticulin
affects the expression of both vinculin and N-cadherin in
cells grown in vitro [3-5], which underlies its role in mod-
ulating cell adhesiveness [6]. Cell adhesion is a recognized
morphogen with a role in cardiac myofibrillogenesis [20-
23]. The major adhesive structures of cardiomyocytes are
the intercalated discs [24,25], part of which are adherens-
type junctions that contain N-cadherin [26]. N-cadherin is
required for proper heart organogenesis as documented
by experiments employing use of function-blocking anti-
bodies [27-30], retroviral expression of dominant-nega-
tive mutants of N-cadherin [31,32] or genetic
manipulation [33,34]. During gastrulation, N-cadherin is
uniformly distributed throughout the heart forming mes-
oderm, and is also uniformly distributed in the tubular
heart [35]. In the developing heart, zonula adherens are
the primary sites of N-cadherin accumulation [26,36-38].
N-cadherin can also be found in non-junctional sarco-
lemma [21,27,39] and mostly in costameres [30,40]. The
expression of N-cadherin in the developing myocardium,
as assessed by Western blotting, gradually increases at pre-
trabeculation stage, after which it remains relatively con-
stant [32]. Importantly, the expression of N-cadherin is
Ultrastructure of ventricular myocardium of WT (A) and calreticulin KO (B) hearts and of atrial myocardium of WT (C) and  calreticulin KO (D) hearts Figure 8
Ultrastructure of ventricular myocardium of WT (A) and calreticulin KO (B) hearts and of atrial myocardium of WT (C) and 
calreticulin KO (D) hearts. It is apparent that there is a substantial difference in the myofibrillar width between the WT and 
KO phenotypes in both ventricles and atria at late stages of development. Further details are found in the text. Magnification 
15,000×.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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Myofibrillar count Figure 9
Myofibrillar count. A: Histogram of an average ventricular myofibrillar count of myofibrils for each phenotype. B: Histogram of 
an average atrial myofibrillar count for each phenotype.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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not as much necessary for myofibrillogenesis per se, as for
continuous alignment of myofibrils between myocytes
[41]. It is thus conceivable that the reduction of N-cad-
herin expression in calreticulin KO hearts that we report
here may underlie the observed myofibrillar disarrange-
ment.
Most myofibrillar proteins are present in the sarcomere
when the fist contractions appear in the developing heart.
Soon thereafter, the myofibrils acquire their finite orienta-
tion along the cell axis, probably by interaction with the
intermediate filament protein, desmin, and with vinculin
in the costameres, which are components of the cardiac
cytoskeleton responsible for transmission of force gener-
ated by the contractile apparatus [21,23,42-46]. Thus, cos-
tameres and intercalated discs are important for proper
myofibrillogenesis [17,24,40,47,48]. Comparison of the
ventricular myocardium in the calreticulin KO versus WT
shows very subtle differences in morphology of the inter-
calated discs. In WT myocardium, intercalated discs cross
the cardiomyocyte in straight lines or in a stepwise fash-
ion. Although there is no detectable morphological differ-
ence between intercalated discs in atria and ventricles of
either phenotype, the intercalated discs of the calreticulin
KO ventricular myocardium are more likely to run in a
stepwise fashion, which is likely caused by intercalated
discs of adjacent myofibrils of the cardiomyocyte not
being in register. As ablation of N-cadherin causes loss of
intercalated discs [34], we presume that the observed
reduction in its expression may interfere with proper
alignment of intercalated discs in calreticulin KO myocar-
dium.
In developing cardiomyocytes, glycogen is abundant as it
is the main energy source [49] and its amount declines
with maturation. Early in embryonic development (12.5
and 13.5 dpc), glycogen is diffusely located throughout
the sarcoplasm. Although glycogen in most tissues is
located within lysosomes, this does not appear to be the
case in the heart. Glycogen particles occur freely in the sar-
coplasm: they are not surrounded by nor are attached to
membranes [50,51]. By 14.5 dpc, glycogen aggregates into
globules and by 18.5 dpc, it is found mainly in large pools
within the sarcoplasm, which is consistent with previous
reports [25]. Calreticulin KO ventricular cardiomyocytes
contain significantly more glycogen than the correspond-
ing WT cardiomyocytes. Moreover, while glycogen con-
tent decreases in WT ventricles, its amount increases with
embryonic development in calreticulin KO ventricles.
Developmental regulation of glycogen content in the
heart has not been well studied. Knaapen et al. [52] report
an increase in glycogen content in rat heart between
embryonic day 11 and 17 and speculate that this increase
may be more structural than metabolic. Accumulation of
glycogen in calreticulin KO and not WT hearts, and in ven-
tricles and not atria, seems to be at odds with a structural
hypothesis for glycogen accumulation in the developing
mouse heart. Glycogen breakdown is mediated by a cas-
cade of events that converts inactive glycogen phosphory-
lase b to active phosphorylase a [49]. Calmodulin, the
Ultrastructure of glycogen deposits in ventricular myocardium of WT (A) and calreticulin KO (B) hearts at 18.5 dpc Figure 10
Ultrastructure of glycogen deposits in ventricular myocardium of WT (A) and calreticulin KO (B) hearts at 18.5 dpc. In calreti-
culin KO ventricular cardiomyocytes, glycogen is present and its abundance noticeably increases with development. Arrows 
point to most prominent deposits of glycogen. Further details are in the text. Magnification 12,600×.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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intracellular calcium-binding regulatory protein, is one of
the subunits of phosphorylase b kinase and thus inositol
trisphosphate-dependent calcium release from the stores
is required for its activation and that of phosphorylase
[53]. As calreticulin is the major source of inositol tri-
sphosphate-releasable calcium [54], its deficiency may
lead to impaired function of calmodulin and accumula-
tion of glycogen. On the other hand, glycogen accumula-
tion in ventricles of calreticulin KO resembles a mild form
of glycogen storage diseases. In the glycogen storage dis-
eases type II (Pompe's disease), type III (Cori's disease),
and type IV (Andersen's disease), cardiac involvement
may occur in humans [55] and mice [56]. In Pompe's dis-
ease, the cardiac muscle cells appear vacuolized by mas-
sive glycogen deposits displacing the myofibrils to the
periphery of the cells [50,57,58]. N-linked glycosylation
occurs during the post-translational modification of lyso-
somal α-glucosidase and it has been reported that muta-
tions of lysosomal 1,4-α-glucosidase affecting its folding
result in Pompe's disease [59-62]. Besides regulating intra-
cellular calcium homeostasis, another major function of
calreticulin is in "quality control" of folding of glyco-
sylated proteins [2]. Since calreticulin functions as a lec-
tin-like molecular chaperone, perhaps it may also be
involved in the folding of the lysosomal 1,4-α-glucosi-
dase. Thus, calreticulin deficiency might lead to improper
function of the α-glycosidase and cause glycogen accumu-
lation.
Many of the features associated with ablation of calreticu-
lin follow a different course in the atria versus the ventri-
cles. Atrial and ventricular cardiomyocytes arise from
distinct cardiac myocyte lineages, and express distinct sub-
sets of contractile proteins genes [63-65]. Thus, the
absence of calreticulin may have both distinct and com-
mon effects on these cardiac phenotypes. At present, it is
not clear if the defects in the calreticulin-deficient myofi-
brils are associated with a direct effect of calreticulin on
Changes in total measurable ventricular glycogen during development Figure 11
Changes in total measurable ventricular glycogen during development. Histogram of total measurable ventricular glycogen for 
each phenotype.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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the structure of the cardiac myofibril itself, or if calreticu-
lin is affecting adhesive proteins, thus causing a structural
change in the myofibrils. Indeed, the calreticulin KO phe-
notype bears similarity to other mutations ablating cell
adhesion proteins [66-70], but especially to the pheno-
types caused by downregulation of N-cadherin
[27,29,33,41,71]. We suggest here that the morphological
changes associated with the absence of calreticulin in the
heart may be due to a defect in the development of the
contractile apparatus and/or a defect in the development
of cardiomyocyte cell adhesiveness.
Conclusion
Calreticulin is temporarily expressed during heart devel-
opment where it is required for proper myofibrillogenesis.
It also appears to affect metabolism of the developing
muscle via either its effects on cellular Ca2+ homeostasis or
its chaperone function. We thus postulate that calreticulin
be considered as a novel cardiac fetal gene.
Methods
Animals
Calreticulin knockout mice were generated by homolo-
gous recombination as described previously by Mesaeli et
al. [11]. All procedures were carried out according to the
animal procedures approved by the University of Toronto.
Dissections
Pregnant female mice at various stages of gestation were
sacrificed by cervical dislocation, their uteri removed and
embryos collected. Embryos were sacrificed by decapita-
tion and the embryonic heads were used for genotyping.
Ultrastructure of intercalated discs of the developing ventricular myocardium Figure 12
Ultrastructure of intercalated discs of the developing ventricular myocardium. Initially, the immature intercalated discs are 
short and thin (A, B). With embryonic development, they become larger, more complex and are accompanied by increasing 
inter-digitations (C, D). Additional details are in the text. Magnification 16,000×.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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The embryos were then transferred into separate 3.5 cm
tissue culture dishes holding fixative solution at room
temperature (RT). All subsequent dissections were per-
formed in this fixative solution. For dissection of the atria,
very thin glass threads made from glass rods pulled over a
Bunsen burner were used to separate the atria from the
rest of the heart. The left and right ventricles were sepa-
rated from each other by cutting through the ventricular
septum with a razor blade.
Sample preparation for TEM
All TEM procedures were at RT. Primary fixation was car-
ried out for 4 hours in a freshly prepared solution of 2.5%
glutaraldehyde and 2% paraformaldehyde in 0.1 M
cacodylate buffer (pH 7.4) containing 1 mM of Ca++ and
1 mM of Mg++. The samples were then washed for 1 hour
in a solution of 7.5% sucrose in cacodylate buffer, fol-
lowed by a second wash for 1 hour in a solution of 15%
sucrose in the same buffer. Secondary fixation with 1%
osmium tetroxide in 0.1 M cacodylate buffer was carried
out for 1 hour. Samples were dehydrated in increasing
concentrations of ethanol (30, 50, 70, 80, 90 and 100%
each twice for 10 min.), followed by propylene oxide for
thirty minutes. Next, samples were infiltrated with a 1:1
mixture of propylene oxide and embedding medium for
1.5 hours, followed by 100% embedding medium.
Embedding in Taab 812 – Araldite 502 resin followed the
formula for a block of medium hardness: Taab 812 – 12.5
g; Araldite – 7.5 g; DDSA (dodecenyl succinic anhydride)
– 27 g; DMP (2, 4, 6, – tri-(dimethylaminomethyl) phe-
nol) – 0.7 g. Overnight polymerization was carried out at
60°C. Standard thick sections of 0.6 to 0.7 μm, and thin
sections of approximately 90 nm were cut with a Drukker
International 2 mm diamond knife on a Reichert-Jung
ultramicrotome. For optimum longitudinal orientation of
the myofibrils, ventricles were cut sagittally and atria were
cut transversely. Copper grids with mesh size 300, diame-
ter 3.05 mm, were used to collect the sections. Thin sec-
tions were stained with 5% uranyl acetate in water for 15
minutes followed by lead citrate for 15 minutes. After
staining, the grids were washed in double distilled water.
TEM data collection
Heart samples were examined with a Hitachi-7000 TEM
and recorded on Kodak Electron Microscope Film nega-
tives. The areas of interest were first photographed at low
magnification of 3,500× – 5,000×, then the inner myocar-
dium was delineated, and the mesh 300 grid squares were
numbered. Areas for data collection by imaging were
selected randomly. A Table of Random Numbers was used
to choose the area to be photographed. Data were col-
lected from digital images of 10,000× negatives, which
were scanned at the resolution of 900 pixels per inch. To
determine the degree of myofibrillar wave-like appear-
ance, sarcomeric internal angles were measured to pro-
duce an average sarcomeric angle. An individual internal
sarcomeric angle was defined as an angle that a straight
line connecting centres of adjacent Z-lines of a sarcomere
makes with a straight line connecting the centres of the
initial and final Z-line of a given myofibril (resultant) as
shown in Fig. 4. All individual internal sarcomeric angles
of a myofibril were then averaged to produce an average
sarcomeric angle for that myofibril. Measurable glycogen
area was defined as an area of at least 0.1 μm2 in size.
Measurements of glycogen pools were done using Adobe
Photoshop. Total measurable glycogen comprises the sum
of all measurable areas occupied by glycogen particles in
μm2 per a standard area of 100 μm2. Data were reported as
total measurable glycogen area per phenotype in μm2. The
Kolmogorov-Smirnov test was used to test for normality
of the distribution of data between the two phenotypes. If
the populations were normally distributed, as in myofi-
brillar count, myofibrillar thickness, and ventricular gly-
cogen accumulation, parametric two-sample t-tests were
performed to test for the difference between phenotypic
groups. If the populations were not normally distributed,
then the non-parametric Wilcoxon rank sum test was
used.
Western blot analysis of the abundance of vinculin and N  cadherin in calreticulin KO and WT hearts of 14 dpc  embryos Figure 13
Western blot analysis of the abundance of vinculin and N 
cadherin in calreticulin KO and WT hearts of 14 dpc 
embryos. Vinculin is abundant in both phenotypes while the 
level of N-cadherin expression is dramatically reduced in KO 
hearts. Cell extract from an established line of mouse 
embryo fibroblasts was run in the lane marked fibroblasts, 
while GAPDH serves as a loading control.BMC Developmental Biology 2006, 6:54 http://www.biomedcentral.com/1471-213X/6/54
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SDS-PAGE and western blotting
Atria and ventricles from 15.5 dpc, postnatal days (P) P1,
P17 and 6-month-old mice were homogenized in ice-cold
lysis buffer (50 mM Tris-HCl, 120 mM NaCl, 0.5% NP-40,
pH 8.0) with protease inhibitor cocktail (Sigma), and
then spun at 14,000 rpm for 15 minutes at 4°C. Samples
were separated by SDS-PAGE and transferred to a nitrocel-
lulose membrane according to a standard protocol [5,14].
All electrophoresis reagents were from Bio-Rad. The nitro-
cellulose membranes (0.2 μm pore size) were from
Micron Separations Inc. Well-characterized goat and rab-
bit anti-calreticulin antibodies [7,8,15,16] were used in
this study. The primary antibodies were used at the fol-
lowing dilutions in TBST: anti-calreticulin 1:300, anti-vin-
culin 1:500 (Sigma), anti-N-cadherin 1:1000 (BD
Transduction Laboratories), and anti-GAPDH 1:3000
(Lab Frontier). All horseradish peroxidase conjugated sec-
ondary antibodies were used at a dilution of 1:10000
(Jackson ImmunoResearch Laboratories). Chemilumines-
cence ECL Plus Western blotting detection reagents were
from Amersham.
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